Competition becomes fierce between new drugs and first-generics

Published: 2003-01-28 07:00:00

Updated: 2003-01-28 07:00:00

Influenced by the sustained growth of ethical market accelerated by a new system of separating drug dispensing from medical practice and the rapid increasing trend of elderly people, multinational pharmaceutical firms have snatched up about 30 percent of the leading 100 items in the domestic mark...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK